Incomplete Adoption of Clinical Laboratory Standards Institute Breakpoints to Detect Carbapenem-Resistant Organisms

Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae.

We reevaluated Enterobacteriaceae disk diffusion breakpoints for the tetracyclines published in the Clinical and Laboratory Standards Institute (CLSI) document M100-S16, which were (susceptible/resistant) >or=19 mm/or=16 mm/or=19 mm/<or=14 mm for minocycline. A collection of 504 recent clinical isolates of Enterobacteriaceae were test...

Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase

We evaluated the impact of revised Clinical and Laboratory Standards Institute (CLSI) breakpoints for broad-spectrum cephalosporins (BSCs) on the susceptibilities of 1,742 isolates of Enterobacter species, Serratia marcescens, Citrobacter freundii, and Morganella morganii. The 2011 CLSI criteria for cefotaxime and ceftazidime reduced the rates of susceptibility by 2.9% and 5.9%, respectively. T...

Do patient data really support the clinical and laboratory standards institute recommendation for lowering third-generation cephalosporin interpretive breakpoints?

laboratory to clinical investigation of carbapenem resistant acinetobacter baumannii outbreak in a general hospital

background: the number of reported cases, infected with carbepenem resistant acinetobacter baumannii (crab) and multi-drug resistant (mdr) acinetobacter species had gradually increased in most pla general hospital wards from april to june in 2007. objectives: we have described the investigation of an outbreak of crab and mdr acinetobacter in pla general hospital, beijing. the prospective and re...

Antifungal Susceptibility Testing: Clinical Laboratory and Standards Institute (CLSI) Methods

G.S. Hall (ed.), Interactions of Yeasts, Moulds, and Antifungal Agents: How to Detect Resistance, DOI 10.1007/978-1-59745-134-5_2, © Springer Science+Business Media, LLC 2012 Abstract Antifungal susceptibility testing has become an important tool for physicians faced with making diffi cult treatment decisions regarding treatment of patients with fungal infections. The Clinical Laboratory and St...